Shopping Basket

Your basket is empty

Moxa treatment improves the effect of standard drug therapy for patients with tuberculosis (TB), according to research carried out by Ugandan and British researchers as part of the Moxafrica project. One hundred and eighty newly diagnosed TB patients were randomly assigned to two groups, one given standard first line drug therapy, and the other drug therapy along with daily self-administered moxibustion. The two groups were carefully monitored for differences in recovery rates and immunological markers. According to sputum tests, the moxa group responded to drug therapy faster than the drug only group. Haemoglobin levels also significantly improved in those treated with moxa. The same positive results were seen in a sub-group of TB patients who were also HIV positive. It was also noted that the moxa patients reported statistically significant better adherence to their drug therapy.

Adjunctive moxibustion treatment for tuberculosis: A randomised clinical trial investigating potential efficacy and comparative safety. Eur J Integ Med. 20(Jun 2018): 90-97.


Not yet subscribed?

Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:

Subscribe now